Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study
2017 ◽
Vol 37
(6)
◽
pp. 603-612
◽
2018 ◽
Vol 118
◽
pp. 80-86
◽
Keyword(s):
2007 ◽
Vol 27
(6)
◽
pp. 628-633
◽
2015 ◽
Vol 82
(8)
◽
pp. 768-769
◽
2021 ◽
Vol 77
(18)
◽
pp. 441
Keyword(s):
2015 ◽
Vol 149
(4)
◽
pp. 971-980.e1
◽
Keyword(s):
2018 ◽
Vol 45
(5)
◽
pp. 529-539
◽